논문 및 학회자료
|
A randomized, double-blind, placebo-controlled, first-in-human single ascending dose, multiple ascending doses, and food effect study to evaluate the safety, tolerability, and pharmacokinetic profile of FM101 in healthy volunteers (EASL 2020)
Admin │ 2021-04-05 HIT 241 |
|---|
|
|
| 이전글 | Preclinical characterization of FM101, a first-in class A3 adenosine receptor mo... |
|---|---|
| 다음글 | Safety Evaluation of FM101, an A3 Adenosine Receptor Modulator, in Rat, for Deve... |